Co.'s swine flu vaccine works in animals

ROCKVILLE, Md. (AP) - August 18, 2009 That's based on a small study scientists at the federal Centers for Disease Control and Prevention did on ferrets, which react to the flu like people.

But the Maryland company's genetically engineered vaccine won't be approved and ready for commercial use in the U.S. for at least a couple years. That means it won't be available to help here in the current epidemic of novel H1N1 influenza.

The company's chief medical officer says the results show what Novavax could do for the next pandemic.

And while the vaccine won't be licensed here for a few years, Novavax is talking to poor countries.